Variant Bio Launches AI Drug Discovery Platform: How AI and Genomics Are Reshaping the Pharmaceutical Industry
Introduction Variant Bio launches AI drug discovery platform at a time when the pharmaceutical industry is under pressure to improve research efficiency and reduce development risk. Drug discovery remains expensive and time intensive, with many programs failing due to weak biological validation. Artificial intelligence is increasingly viewed as a solution to these structural challenges. When […]






